PFHxA in the Bedroom

At a glance

What it is

PFHxA — perfluorohexanoic acid, CAS 307-24-4 — is the 6-carbon perfluoroalkyl carboxylic acid that structurally parallels PFOA except for the two-carbon difference in chain length (C6 vs C8). Every carbon bears fluorine atoms, and the C–F bonds are among the strongest in organic chemistry — the same chemistry that makes PFOA persistent applies to PFHxA. The shorter chain affects toxicokinetics (human half-life ~32-42 days vs PFOA's 2-3+ years) but does not affect environmental persistence.

The PFHxA commercial story starts in 2006 when the US EPA launched the PFOA Stewardship Program — a voluntary agreement with 3M, DuPont, Daikin, and others to phase out long-chain perfluoroalkyl carboxylates by 2015. The replacement chemistry that absorbed most of the displaced market was C6 fluorotelomer-based: 6:2 fluorotelomer alcohols, sulfonates, and derived polymers. These C6 precursors are used in DWR coatings, paper food contact treatments, and other applications where long-chain PFOA-precursor chemistry had been dominant. The precursors break down environmentally and metabolically to release PFHxA — which is why PFHxA appears in biomonitoring data even when consumers don't directly purchase or apply "PFHxA."

Where you encounter it

From durable water repellent (DWR) coatings on outdoor clothing

The largest exposure pathway for general-population PFHxA via consumer products. Outdoor rain jackets, ski jackets, hiking pants, technical outerwear, and waterproof boots manufactured since approximately 2015 use C6 fluorotelomer-based DWR systems in most price tiers. Major outdoor apparel brands (Gore-Tex/W.L. Gore, Patagonia, REI, Columbia, The North Face, and many others) transitioned through the late 2010s. Some brands have moved further to non-fluorinated DWR alternatives (silicone-based, wax-based) by the mid-2020s, but C6 fluorotelomer chemistry remains dominant in current production. The compound migrates from treated fabric into household dust and into skin contact during wear.

From stain-resistant carpet and upholstery

Post-2015 carpet stain-resistance treatments and upholstery durable-finish systems shifted from long-chain PFAS to C6 fluorotelomer chemistry. Treated carpet, sofa fabric, dining chair upholstery, automotive interior fabrics — the post-2015 reformulation cycle introduced PFHxA-precursor chemistry across these product categories. Karásková and colleagues 2016 in Environment International documented short-chain PFAS including PFHxA in household dust samples from Central Europe and North America. Peer-reviewed The dust reservoir is the dominant residential PFAS exposure pathway after dietary and drinking water for non-occupational populations.

From firefighter turnout gear

PFAS-treated outer shell fabric in firefighter turnout gear historically used C8 chemistry through approximately 2015, when manufacturer reformulations shifted toward C6 fluorotelomer DWR systems. Specific models, manufacture years, and treatment specifications vary by gear manufacturer (Globe, MSA, Honeywell, Lion, and others). PFAS-free turnout gear certified to NFPA 1971 has been available from multiple manufacturers since 2022-2024, but most active-service gear was manufactured under earlier specifications and continues to carry PFHxA-precursor chemistry. The take-home contamination pathway documented for PFOA and PFOS applies in parallel: contaminated gear stored in or near sleeping areas releases PFAS into household dust over time.

From food packaging

Grease-resistant paper food packaging — fast food wrappers, microwave popcorn bags, pizza boxes, paper bowls for hot foods — historically used long-chain PFAS for oil-repellent properties. The FDA voluntary phase-out of long-chain PFAS food contact substances during 2020-2024 accelerated C6 PFHxA-precursor adoption. Schaider, Balan, Blum and colleagues 2017 in Environmental Science & Technology Letters documented PFAS in fast-food packaging samples collected from US restaurants. Peer-reviewed Dietary PFHxA exposure has been measured in the US population through CDC NHANES biomonitoring at low but detectable serum concentrations.

From "fluorine-free" AFFF firefighting foams

Some firefighting foams marketed as "fluorine-free" have been documented to contain residual or trace PFHxA and other short-chain PFAS, either through cross-contamination in manufacturing or from undisclosed C6 precursors. Independent third-party testing of "fluorine-free" foam claims has flagged this pattern multiple times since 2020. Speculation — the prevalence of cross-contamination in marketed fluorine-free foams is documented case-by-case rather than at industry-wide scale Verifying manufacturer fluorine-free claims with independent testing is the actionable level of confidence.

From air emissions and atmospheric transport

6:2 fluorotelomer precursors are volatile or semi-volatile and break down in the atmosphere over weeks to months, releasing PFHxA as a persistent degradation product. Atmospheric measurements have documented PFHxA accumulating in Arctic regions thousands of kilometers from any direct emission source — the compound is one of the more atmospherically mobile PFAS in current production. The remote-region accumulation pattern is what drove the EU REACH "universal PFAS restriction" framing: short-chain PFAS that are environmentally mobile and persistent reach geographic regions where they cannot be addressed through localized regulation.

From indoor dust and drinking water

Indoor dust accumulates PFHxA and PFHxA precursors at measurable concentrations, particularly in homes with extensive treated-textile inventory. Drinking water near textile manufacturing, fire training areas, and certain industrial sites shows elevated PFHxA. The US EPA 2024 PFAS NPDWR does not establish an individual MCL for PFHxA or include PFHxA in the Hazard Index — the federal regulatory framework currently leaves PFHxA monitoring and remediation to state-level action, of which many states have implemented their own PFAS standards.

What the research says

Toxicokinetics — the C6 short-chain framing

Russell, Nilsson, and Buck 2013 in Chemosphere reported the foundational pharmacokinetic study of PFHxA in human volunteers and characterized the human serum half-life at approximately 32 days. Peer-reviewed — foundational PFHxA pharmacokinetic study Subsequent studies have refined the estimate to roughly 32-42 days depending on study population. The shorter half-life is the central toxicokinetic differentiator from PFOA and the basis for the C6 chemistry replacement marketing — body burden at steady-state chronic exposure is lower than for the equivalent PFOA exposure because elimination outpaces accumulation more effectively. The shorter half-life does not change the underlying mechanism-of-action concerns for the PFAS class.

Hepatic, developmental, and immune effects

Iwabuchi, Sumiyoshi and colleagues 2017 and earlier subchronic studies have characterized PFHxA hepatic effects in rats — liver weight increase, hepatocyte hypertrophy, and effects on lipid metabolism at chronic exposure. Peer-reviewed The hepatic finding is consistent across the PFAS class. Developmental and reproductive endpoints have been characterized in rodent studies at higher doses; the human dose-response at typical residential exposure levels is less precisely characterized than for PFOA.

The EU REACH restriction proposal

Germany submitted the REACH Annex XV restriction dossier on PFHxA, its salts, and PFHxA-related substances in late 2019 (BAuA-FB201912). ECHA's Committee for Risk Assessment (RAC) and Committee for Socio-Economic Analysis (SEAC) developed opinions through 2020-2021, both supporting the proposed restriction. Regulatory The European Commission has been working through the final adoption procedure since. The REACH restriction process typically runs 2-3+ years from RAC/SEAC opinions to enforceable EU restriction with specific product-category restrictions and effective dates. As of 2026, the PFHxA restriction is at the late-stage implementation phase. The broader EU "universal PFAS restriction" jointly submitted by Germany, the Netherlands, Norway, Sweden, and Denmark in February 2023 covers PFHxA as part of a much larger set of approximately 10,000 PFAS substances.

The regrettable substitution framing

Wang, Cousins, Scheringer and Hungerbühler 2013 in Environment International wrote the foundational analysis of fluorinated alternatives to long-chain PFAS and articulated the "regrettable substitution" concern: the C6 and C4 replacement chemistries share the environmental persistence that drove the PFOA/PFOS regulatory cycle, and the population-level burden of short-chain PFAS is increasing globally despite the long-chain phase-out. Peer-reviewed — foundational regrettable substitution analysis Subsequent papers from the same research group have extended the framing to specific compound classes including PFHxA.

Human epidemiology — emerging

PFHxA human epidemiological evidence is less mature than for PFOA, primarily because PFHxA environmental measurement started later (post-2015 reformulation cycle) and the long-latency disease outcomes that define the PFOA literature (cancers, cardiovascular disease, fertility) require multi-decade follow-up that has not yet been completed for PFHxA-specific exposure. CDC NHANES biomonitoring shows PFHxA in US adult serum at lower concentrations than PFOS or PFHxS but consistently detectable. Inferred from the general PFAS-class epidemiology timeline; PFHxA-specific disease-association studies are still accumulating The EU regulatory action is proceeding on the basis of animal toxicology, environmental persistence, and the precautionary application of the dose-additive PFAS framework.

What helps reduce exposure

For outdoor clothing and gear: choose untreated or non-fluorinated DWR alternatives. Silicone-based and wax-based DWR systems are increasingly available. Patagonia, Páramo, Fjällräven, and others have eliminated PFAS from much of their lines as of 2024-2026.

For carpet and upholstery: choose untreated or certified PFAS-free products when buying new. Replacement with untreated wool, cotton, or third-party-verified alternatives reduces ongoing dust contribution.

For drinking water in affected areas: install certified PFAS-removal filtration. NSF/ANSI 58 (reverse osmosis) is most thoroughly validated for residential PFHxA reduction; certain NSF/ANSI 53 GAC filters work — verify the certification covers PFHxA.

For firefighters: enforce the take-home contamination protocol. Change at the station, store contaminated gear outside bedrooms, wash work clothing separately. Advocate department-level transitions to PFAS-free turnout gear and fluorine-free foams with third-party verification.

Avoid grease-resistant paper food packaging where alternatives exist. Reusable containers, ceramic plates, and untreated fiber-based packaging eliminate the food-contact pathway.

HEPA-vacuum carpets and upholstery weekly. The indoor dust reservoir contains the household PFHxA load that has migrated from treated textiles over years of use.

What does NOT help

• "C6 chemistry" or "short-chain PFAS" labels as safety claims. PFHxA is C6 chemistry — this page is about it. The EU is actively restricting C6 PFAS under REACH; the "short-chain" marketing framing is not regulatorily endorsed.
• "PFOA-free" claims. Do not address C6 replacements. Many "PFOA-free" products contain PFHxA precursors that ultimately yield PFHxA.
• "Fluorine-free" claims without third-party verification. Independent testing has documented PFAS contamination in some "fluorine-free" products from manufacturing cross-contamination or undisclosed precursors.
• Generic activated carbon water filters without certification. Standard activated carbon filters without NSF certification have variable PFAS-reduction performance. The certification language is the actionable verification.
• Boiling water. Concentrates rather than removes PFAS.
• Discarding all treated textiles immediately. The mitigation is product choice on replacement, not immediate disposal of all existing inventory.

Open research questions

• Bioactive half-life of PFHxA precursors after metabolic degradation — precursors that break down to PFHxA contribute to total body burden via the released PFHxA, but the metabolic kinetics of specific 6:2 fluorotelomer precursors are not fully characterized. Speculation
• Chronic low-dose effects below current EPA/EFSA reference values — PFHxA human epidemiology is less mature than for long-chain PFAS, and the long-latency disease outcomes that define the PFOA literature have not yet been studied for PFHxA-specific exposure with adequate follow-up time. Speculation re: long-latency outcomes; established for animal short-term endpoints
• EU REACH restriction implementation timeline and global harmonization — the EU restriction is at the late-stage implementation phase; US federal PFHxA-specific MCL is not anticipated near-term. Inferred from current EU/US regulatory priorities

Citations

1. Russell MH, Nilsson H, Buck RC (2013). Elimination kinetics of perfluorohexanoic acid in humans and comparison with mouse, rat and monkey. Chemosphere, 93(10):2419-2425. DOI 10.1016/j.chemosphere.2013.04.072 Peer-reviewed — foundational PFHxA pharmacokinetic study; ~32-day human half-life
2. European Chemicals Agency (ECHA). REACH Annex XV Restriction Report — Proposal for restriction of undecafluorohexanoic acid (PFHxA), its salts and PFHxA-related substances. Germany 2019 submission. echa.europa.eu Regulatory — EU REACH restriction process
3. European Chemicals Agency. Universal PFAS restriction proposal — submitted February 2023 by Germany, the Netherlands, Norway, Sweden, and Denmark; covers PFHxA among approximately 10,000 PFAS substances. echa.europa.eu/hot-topics/pfas Regulatory
4. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Perfluoroalkyls — covers PFHxA section. atsdr.cdc.gov/ToxProfiles/tp200.pdf Regulatory
5. Wang Z, Cousins IT, Scheringer M, Hungerbühler K (2013). Fluorinated alternatives to long-chain perfluoroalkyl carboxylic acids (PFCAs), perfluoroalkane sulfonic acids (PFSAs) and their potential precursors. Environment International, 60:242-248. DOI 10.1016/j.envint.2013.08.021 Peer-reviewed — foundational regrettable substitution analysis
6. Karásková P, Venier M, Melymuk L, Bečanová J, Vojta Š, Prokeš R, Diamond ML, Klánová J (2016). Perfluorinated alkyl substances (PFASs) in household dust in Central Europe and North America. Environment International, 94:315-324. DOI 10.1016/j.envint.2016.05.031 Peer-reviewed
7. Schaider LA, Balan SA, Blum A, Andrews DQ, Strynar MJ, Dickinson ME, Lunderberg DM, Lang JR, Peaslee GF (2017). Fluorinated compounds in U.S. fast food packaging. Environmental Science & Technology Letters, 4(3):105-111. DOI 10.1021/acs.estlett.6b00435 Peer-reviewed
8. Klaunig JE, Shinohara M, Iwai H, Chengelis CP, Kirkpatrick JB, Wang Z, Bruner RH (2015). Evaluation of the chronic toxicity and carcinogenicity of perfluorohexanoic acid (PFHxA) in Sprague-Dawley rats. Toxicologic Pathology, 43(2):209-220. DOI 10.1177/0192623314530532 Peer-reviewed
9. Interstate Technology and Regulatory Council (ITRC) PFAS Team. PFAS Technical and Regulatory Guidance Document. pfas-1.itrcweb.org Regulatory — multi-state regulatory consortium
10. US Environmental Protection Agency. Per- and Polyfluoroalkyl Substances (PFAS) — main agency PFAS page including 2024 NPDWR final rule and ongoing PFAS regulatory actions. epa.gov/sdwa/pfas Regulatory

Frequently asked questions

• Is PFHxA safer than PFOA?

  PFHxA has a substantially shorter biological half-life in humans (~32-42 days) than PFOA (~2-3+ years), which is the central toxicokinetic argument for the C6 chemistry replacement. The shorter half-life limits chronic body burden accumulation at steady-state exposure. PFHxA shares the same environmental persistence as PFOA — the C–F bond chemistry that makes the whole PFAS class non-degradable. The EU REACH restriction proposal led by Germany (2023) reflects the regulatory determination that "shorter chain" alone is not sufficient grounds to consider PFHxA acceptable. The US EPA has not finalized a federal MCL for PFHxA and PFHxA is not included in the 2024 PFAS NPDWR Hazard Index — the regulatory momentum on PFHxA is currently led by the EU.

• Is PFHxA in Scotchgard?

  Some of the "reformulated Scotchgard" chemistry is C6-based, but 3M's primary post-2002 short-chain Scotchgard reformulation used PFBS chemistry (C4 sulfonate) rather than PFHxA-based systems directly. PFHxA more commonly appears as a metabolite/breakdown product of fluorotelomer-based DWR chemistries that other manufacturers (W.L. Gore, DuPont/Chemours, Daikin, and others) have used for textile water and stain repellent applications. Many post-2015 outdoor clothing, upholstery, and carpet treatments use 6:2 fluorotelomer precursors that degrade to PFHxA in the environment and metabolically. The PFHxA detection in indoor dust generally reflects this precursor-degradation pathway rather than direct PFHxA application.

• What products contain PFHxA?

  PFHxA itself is rarely the direct ingredient — it most commonly appears as the breakdown product of 6:2 fluorotelomer-based chemistry used in durable water repellent (DWR) coatings on outdoor clothing and gear, stain-resistant upholstery and carpet treatments, grease-resistant paper food packaging (fast food wrappers, microwave popcorn bags, pizza boxes), firefighter turnout gear outer-shell DWR systems manufactured under post-2015 specifications, and "fluorine-free" AFFF firefighting foams that contain residual C6 PFAS. PFHxA precursors break down in the environment and in human metabolism to release PFHxA over time, which is why PFHxA appears in biomonitoring data even when products are not labeled as containing it directly.

• How long does PFHxA stay in the body?

  The biological half-life of PFHxA in humans is approximately 32 to 42 days based on Russell and colleagues' pharmacokinetic studies. That's substantially shorter than PFOA (2-3+ years) but still slow enough that continuous exposure produces meaningful steady-state body burden. Stopping exposure produces measurable serum PFHxA reduction over weeks to months. The kinetics are why the regulatory framing for PFHxA differs from PFOA — chronic exposure dose-response is less concerning at the same external concentration because elimination outpaces accumulation more effectively — but the chemistry is environmentally persistent, so ongoing low-level dietary, drinking water, and dust exposure continues to add to body burden indefinitely.

• Is PFHxA banned in Europe?

  Not yet banned, but the EU REACH restriction proposal is active. Germany submitted the Annex XV restriction dossier on PFHxA, its salts, and PFHxA-related substances in late 2019, and ECHA's Committee for Risk Assessment (RAC) and Committee for Socio-Economic Analysis (SEAC) developed opinions through 2021. The EU Commission has been working through the REACH restriction procedure since — the timeline from RAC/SEAC opinions to enforceable EU restriction typically runs 2-3+ years. As of 2026, the PFHxA restriction is at the late-stage regulatory implementation phase but specific product-category restrictions and effective dates depend on the final adopted text. The broader EU REACH "universal PFAS restriction" proposal submitted jointly by Germany, the Netherlands, Norway, Sweden, and Denmark in 2023 covers PFHxA among a much larger set of PFAS.

• Is PFHxA in firefighter gear?

  Yes, in many active-service turnout gear inventories. PFAS-treated outer shell fabric historically used C8 chemistry through approximately 2015, when manufacturer reformulations shifted toward C6 (PFHxA-based via fluorotelomer DWR) and C4 (PFBS-based) systems. Specific models, manufacture years, and treatment specifications vary by gear manufacturer (Globe, MSA, Honeywell, Lion, and others). PFAS-free turnout gear certified to NFPA 1971 has been available from multiple manufacturers since 2022-2024, but most active-service gear was manufactured under earlier specifications and continues to carry PFAS chemistry through its useful life. The take-home contamination pathway documented for PFOA and PFOS in firefighter populations applies in parallel to PFHxA.

• What's the difference between C6 and C8 PFAS?

  C6 and C8 refer to the perfluoroalkyl chain length — C8 PFAS have 8 perfluorinated carbons (PFOA, PFOS), C6 PFAS have 6 perfluorinated carbons (PFHxA, PFHxS). The chain length affects toxicokinetics: longer chains have substantially longer human serum half-lives (PFOA ~2-3+ years; PFHxA ~32-42 days; PFBS ~25-46 days). Shorter chains are also more water-mobile and less bioaccumulative in fish and wildlife. The "C6 replacement chemistry" that dominated post-2015 reformulation activity (Scotchgard, Teflon-coated cookware processing, firefighter gear DWR) was marketed on the shorter-half-life argument. The environmental persistence is the same across chain lengths — all carbon-fluorine bonds in any PFAS resist environmental degradation. The "regrettable substitution" concern is that C6 and C4 chemistry continues to add to global PFAS environmental burden indefinitely.

Related compounds

• PFOA — the C8 perfluoroalkyl carboxylate that PFHxA replaced; subject of the 2006-2015 EPA Stewardship Program phase-out
• PFOS — C8 perfluoroalkyl sulfonate; subject of the 2000-2002 3M voluntary phase-out
• PFHxS — C6 perfluoroalkyl sulfonate sibling; sibling in the EPA 2024 Hazard Index calculation
• PFNA — C9 perfluoroalkyl carboxylate; sibling in the EPA 2024 Hazard Index calculation
• PFBS — C4 perfluoroalkyl sulfonate; sibling short-chain PFAS; sibling in the EPA 2024 Hazard Index calculation
• GenX (HFPO-DA) — the fluoropolymer manufacturing aid PFOA replacement; sibling in the EPA 2024 Hazard Index calculation
• 6:2 FTS — fluorotelomer sulfonate; 6:2 fluorotelomer precursors degrade to PFHxA in environment and metabolism

Embr Sleep is a sleep environment company researching the chemistry of the bedroom. See the methodology page for how this Atlas tags claims by evidence strength. For broader context on PFAS exposure pathways and firefighter take-home contamination, see non-toxic bedroom and farm family sleep.

Last reviewed 2026-05-25. If you find a factual error, contact us.